1-3 of 3
Cécile Acquaviva
Close
Sort by
Journal Articles

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn, Cécile Acquaviva, Eva Fronkova, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert
Journal: Blood
Blood (2007) 110 (12): 4022–4029.
https://doi.org/10.1182/blood-2007-04-082040
Published: 2007
Includes: Supplemental data
Journal Articles

Asparagine Depletion, Safety and Antibody Production after E Coli Asparaginase Treatment in Children with Newly Diagnosed Acute Lymphoblastic Leukaemia Treated with EORTC 58951 Protocol: A Single Center Report.

Yves Bertrand, MD, Marie Pierre Goutagny, CRA, Anne Lise Poulat, MD, Sandrine Girard, PhD, Cecile Acquaviva, PhD, Christine Vianey Saban, PhD, Claudine Vermot-Desroches, PhD, Laurence Bourdin, CRA, Cedric Alex, CRA, Eric Rougemond, PhD, Kamila Kebaili, MD
Journal: Blood
Blood (2007) 110 (11): 4337.
https://doi.org/10.1182/blood.V110.11.4337.4337
Published: 2007
Journal Articles

Prognostic Impact of MRD in the Bone Marrow of Children at First Isolated Extramedullary Relapse of ALL.

Nikola Hanzsch, Cornelia Eckert, PhD, Cecile Acquaviva, PhD, Eva Fronkova, Arend von Stackelberg, MD, Udo zur Stadt, PhD, Andre Schrauder, MD, Jan Trka, PhD, MD, Karl Seeger, PhD, MD, Guenter Henze, MD, Helene Cave, PhD
Journal: Blood
Blood (2004) 104 (11): 1087.
https://doi.org/10.1182/blood.V104.11.1087.1087
Published: 2004